DLL1 and neoplasm: DLL3, one of the ligands of the Notch signaling pathway located in the cell membrane of tumor cells, is often expressed in neuroendocrine tumors and exerts an inhibition of DLL1/NOTCH interaction, causing an inhibition of the Notch pathway [30,31].